E-Rare aims at maximising the efficiency and impact of research on rare diseases on a European scale.
The call objective is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach. The research projects have to focus on the pre-clinical development of therapeutic approaches in suitable existing animal or cell models. The therapeutic approaches can include cell-based therapy, gene therapy and pharmacological therapy.
Interested researchers are requested to contact the Swiss National Science Foundation (SNSF) Administrative Offices to clarify eligibility issues before submitting their pre-proposal.
For further details, please refer to the programme’s official website. The submission deadline for pre-proposals is 1 February 2017.